Nepidermin

N/A

Report date: 2022/02/21 14:02:18

Base Information

Drug NameNepidermin
Drug Alias NameRecombinant human epidermal growth factor (Daewoong)rhEGF (Daewoong)EasyefDWP-401
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsAlopeciaDiabetic FootDry Eye Syndromes
Global Approved IndicationsAlopeciaDiabetic Foot
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2001/01/01
Country/TerritoryEgyptJordanSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesDaewoong Bio Inc
Active IndicationsAlopeciaDiabetic Foot
Inactive IndicationsDry Eye Syndromes

Other Information

ATC CodeD03
Related LinksWikipedia